Lupin Pharmaceuticals recalls 10mg Amlodipine Besylate tablets due to subpotent drug levels. Affected lots may not provide intended medication strength. No remedy specified in official notice.
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
Lupin Pharmaceuticals is recalling 10mg Amlodipine Besylate tablets that may not contain the correct medication strength. This could lead to ineffective treatment if used without proper medical supervision.
The tablets failed a stability test showing lower-than-stated drug concentration. This means the medication may not work as intended, potentially leading to inadequate blood pressure control.
Patients prescribed this medication by a doctor who received the recalled lot. Those with specific medical conditions requiring precise blood pressure control may be most affected.
Check for the product name 'Amlodipine Besylate Tablets, USP 10 mg', 1000-count bottles, and the lot number A102887. The expiration date is June 2023.
Verify the product name, strength, and lot number on the label to confirm if it matches the recalled items.
The official notice does not specify any remedy.
It means the medication may contain less active ingredient than labeled, potentially reducing effectiveness.
Look for the lot number A102887 on the 1000-count bottles of 10mg Amlodipine Besylate Tablets, USP.
We’ve drafted a message you can send Lupin Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0899-2023 — Lupin Pharmaceuticals Lupin Pharmaceuticals Hello, I own a Lupin Pharmaceuticals that is covered by recall D-0899-2023 from Lupin Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
